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Mayaro Virus 
Infection in 
Traveler Returning 
from Amazon Basin, 
Northern Peru
To the Editor: We report the case 
of a 27-year-old male Swiss tourist 
who spent 3.5 weeks (July 6–30, 2011) 
vacationing in the vicinity of Tarapoto, 
a small city located in the rainforests 
of the Amazon Basin in northern Peru. 
An acute febrile illness developed 
in the man during the second week 
of his stay. Signs and symptoms of 
illness were chills, malaise, frontal 
headache, generalized myalgia, a self-
limiting painful cervical and inguinal 
lymphadenopathy (lasting ≈1 week), 
slowly progressive and pronounced 
polyarthralgic pains of the peripheral 
joints, and a transient nonpruritic 
maculopapular rash (starting at the 
forearms ≈1 week after onset of fever 
and spreading to the trunk and later to 
the neck and face before fading after 
3 days).
The traveler sought care at the 
local hospital, where physicians 
diagnosed suspected dengue fever 
on the basis of the clinical signs and 
symptoms, and received symptomatic 
treatment with paracetamol. The fever 
and other signs subsided within 1 
week, except the arthralgia, which 
did not improve. The polyarthritis 
initially was accompanied by swelling 
of the affected joints and showed a 
symmetric pattern, mainly affecting 
the small joints of the hands and feet as 
well as the wrists, ankles, and knees.
After returning home to 
Switzerland, the patient consulted his 
general practitioner (August 1, 2011) 
because of persisting, incapacitating 
joint pains. The patient reported 
stiffness of the affected joints, mainly 
in the morning and after immobility. 
Physical examination of the affected 
joints did not reveal visible clinical 
signs of infl ammation (swelling, 
redness, effusion). Laboratory tests 
were performed for complete blood 
count, liver and kidney function, 
C-reactive protein, and serologic 
testing for dengue virus, chikungunya 
virus, Borrelia burgdorferi, 
Chlamydia trachomatis, Epstein-Barr 
virus, parvovirus B19, Salmonella 
Typhi, and S. Paratyphi, but none 
revealed a cause for the symptoms. 
Over almost 2 more months, the joint 
pains did not improve; thus, the patient 
was referred to a rheumatologic 
clinic and subsequently to the Swiss 
Tropical and Public Health Institute, 
Basel, Switzerland, for evaluation of 
a putative travel-related cause of the 
polyarthralgia.
Because of the patient’s travel 
history, the course of the illness 
and clinical signs and symptoms 
experienced during the journey, and 
the evolution and characteristics 
of the persisting joint pains, we 
suspected an underlying Mayaro 
virus (MAYV) infection. Serologic 
testing (indirect immunofl uorescence 
and virus neutralization assays) for 
several alphaviruses were performed 
as described (1), and the results 
(Table) confi rmed our presumptive 
diagnosis.
Several viral infections (e.g., 
dengue, rubella, parvovirus B19, 
hepatitis B, hepatitis C, HIV, and 
human T-lymphotropic virus type 1) 
can be accompanied by arthralgia. 
However, the most prominent and 
long-lasting polyarthritic symptoms 
occur in patients infected by 
alphaviruses (family Togaviridae).
Alphaviruses are arthropod-borne 
viruses (arboviruses) that circulate 
among a wide variety of wild animals 
in relative mosquito vector–specifi c 
and host-specifi c enzootic cycles; 
infection in humans (dead-end hosts) is 
almost exclusively incidental. Clinical 
cases and virus isolation have been 
reported only from northern South 
America, where MAYV circulates 
in an enzootic sylvatic cycle (similar 
to that for yellow fever) involving 
forest-dwelling Haemagogus spp. 
mosquitoes as vectors and nonhuman 
primates as natural hosts (2). 
Infections in humans mostly occur 
sporadically, are strongly associated 
with occupational or recreational 
exposure in rainforest environments, 
and are assumed to represent spillover 
from the enzootic cycle (2).
MAYV was fi rst isolated in 
Trinidad in 1954; since then, sporadic 
cases, clusters, outbreaks, and small 
epidemics of Mayaro fever have 
been reported from Brazil, Bolivia, 
Columbia, French Guiana, Guyana, 
Peru, Venezuela, and Surinam (3). In 
addition to the clinical cases and virus 
isolates reported from northern South 
America, serologic survey fi ndings 
suggest the presence of MAYV in Costa 
Rica, Guatemala, and Panama (4) 
(online Appendix Figure, wwwnc.cdc.
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Clinical signs of this acute, 
dengue-like, febrile illness last 
3–7 days and typically include 
chills, headache, retro-orbital and 
epigastric pain, myalgia, arthralgia, 
nausea, vomiting, diarrhea, and a 
maculopapular rash (sometimes 
followed by desquamation) (7). 
However, as with other alphavirus 
infections (i.e., chikungunya [Africa, 
Asia], o’nyong-nyong [Africa], Ross 
River [Australia, Oceania], Barmah 
Forest [Australia], and Sindbis [Africa, 
Europe, Asia, Australia]), the hallmark 
of MAYV infection is the highly 
debilitating arthralgia. Permanent 
damage of the affected joints has 
not been reported. Hemorrhagic 
manifestations of MAYV infections 
are rare but have been described (3). 
Concerns over the potential emergence 
of urban transmission of MAYV were 
raised after a laboratory study showed 
vector competence of Aedes aegypti 
mosquitoes (8).
International travelers are rarely 
given a diagnosis of MAYV infection 
(9,10). This might be attributed to the 
overall low frequency of the infection; 
the dengue-like signs and symptoms, 
which may lead to a misdiagnosis; 
and the fact that the disease is not 
well known outside MAYV-endemic 
regions. Physicians treating patients 
with signs and symptoms of a dengue-
like illness and a recent history of 
travel to MAYV-endemic areas should 
consider MAYV infection in the 
differential diagnosis, especially if 
arthralgia is prominent and prolonged 
and dominates the clinical picture.
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Table. Results of serologic testing for a Mayaro virus–infected Swiss traveler returning from the Amazon Basin, northern Peru, 2011* 
Virus
Antigenic
complex 
Indirect immunofluorescence assay Virus neutralization assay 
First serum sample† Second serum sample‡ First serum 
sample†
Second serum 
sample‡IgG IgM IgG IgM 
Mayaro virus SF 2,560 1,280 2,560 40  40 160 
Chikungunya virus SF 160 <20 160 <20  ND ND 
O`Nyong-nyong virus SF 20 <20 80 <20  ND ND 
Ross River virus SF 160 <20 160 <20  ND ND 
Semliki Forest virus SF 80 <20 80 <20  20 20 
Barmah Forest virus BF 20 <20 20 <20  ND ND 
Venezuelan equine encephalitis virus VEE 80 <20 80 <20  ND ND 
Western equine encephalitis virus WEE 80 <20 80 <20  ND ND 
Sindbis virus WEE 160 <20 160 <20  <20 <20 
Eastern equine encephalitis virus EEE <20 <20 <20 <20  ND ND 
*SF, Semliki Forest; ND, not done; BF, Barmah Forest; VEE, Venezuelan equine encephalitis; WEE, Western equine encephalitis; EEE, Eastern equine 
encephalitis. 
†Sample obtained August 29, 2011. 
‡Sample obtained September 12, 2011. 
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